Search

James Schultz

Examiner (ID: 14322, Phone: (571)272-0763 , Office: P/1633 )

Most Active Art Unit
1633
Art Unit(s)
1633, 1631, 1635
Total Applications
977
Issued Applications
385
Pending Applications
182
Abandoned Applications
415
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 773121 [patent_doc_number] => 07001723 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-21 [patent_title] => 'Catalytic RNAs with aminoacylation activity' [patent_app_type] => utility [patent_app_number] => 09/721414 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 14 [patent_no_of_words] => 5899 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001723.pdf [firstpage_image] =>[orig_patent_app_number] => 09721414 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/721414 		Catalytic RNAs with aminoacylation activity Nov 21, 2000 Issued
09/600330 Method for selecting ribozymes which are capable of covalently modifying the ribonucleic acids on 2'-oh-groups in trans Nov 13, 2000 Abandoned
09/706580 Ecdysone-inducible adeno-associated virus expression vectors Nov 2, 2000 Abandoned
09/695451 Antisense modulation of TNFR1 expression Oct 23, 2000 Abandoned
Array ( [id] => 1407355 [patent_doc_number] => 06528262 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Method for enrichment of natural antisense messenger RNA' [patent_app_type] => B1 [patent_app_number] => 09/680420 [patent_app_country] => US [patent_app_date] => 2000-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 7684 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528262.pdf [firstpage_image] =>[orig_patent_app_number] => 09680420 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/680420 		Method for enrichment of natural antisense messenger RNA Oct 5, 2000 Issued
09/667018 Antisense modulation of caspase 2 expression Sep 19, 2000 Abandoned
09/661760 Control of hunger, satiety, and food intake by modulating expression and activity of cephalic g protein-coupled receptors Sep 13, 2000 Abandoned
09/659860 Antisense modulation of caspase 7 expression Sep 10, 2000 Abandoned
09/650012 Method and reagent for the induction of graft tolerance and reversal of immune responses Aug 27, 2000 Abandoned
Array ( [id] => 1302291 [patent_doc_number] => 06620585 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Use of ectoenzymes and secreted enzymes to monitor cellular proliferation' [patent_app_type] => B1 [patent_app_number] => 09/630929 [patent_app_country] => US [patent_app_date] => 2000-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 32082 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620585.pdf [firstpage_image] =>[orig_patent_app_number] => 09630929 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/630929 		Use of ectoenzymes and secreted enzymes to monitor cellular proliferation Aug 1, 2000 Issued
09/629543 Nucleozymers Jul 30, 2000 Abandoned
09/602458 Active probe and target detection Jun 22, 2000 Abandoned
09/582055 ADJUVANTED VACCINE FORMULATION Jun 20, 2000 Abandoned
09/486815 ANTISENSE TREATMENT OF PULMONARY HYPERTENSION Jun 18, 2000 Abandoned
09/592007 Use of viral vectors and charged molecules for gene therapy Jun 11, 2000 Abandoned
Array ( [id] => 7616994 [patent_doc_number] => 06946447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-20 [patent_title] => 'MDM2-specific antisense oligonucleotides' [patent_app_type] => utility [patent_app_number] => 09/541848 [patent_app_country] => US [patent_app_date] => 2000-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 57 [patent_no_of_words] => 18536 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946447.pdf [firstpage_image] =>[orig_patent_app_number] => 09541848 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/541848 		MDM2-specific antisense oligonucleotides Apr 2, 2000 Issued
09/536971 Liposomal phosphodiester, phosphorothioate, and p-Ethoxy oligonucleotides Mar 27, 2000 Abandoned
Array ( [id] => 1369838 [patent_doc_number] => 06562569 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Arrays with modified oligonucleotide and polynucleotide compositions' [patent_app_type] => B1 [patent_app_number] => 09/524092 [patent_app_country] => US [patent_app_date] => 2000-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14302 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562569.pdf [firstpage_image] =>[orig_patent_app_number] => 09524092 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/524092 		Arrays with modified oligonucleotide and polynucleotide compositions Mar 12, 2000 Issued
09/446804 3'-Monophosphorylating oligonucleotides Mar 7, 2000 Abandoned
09/514339 Method for therapy of rheumatoid arthritis Feb 27, 2000 Abandoned
Menu